April 2025
1. CHEN W, Jiang Y, Zeng J, Liu D, et al
   FDX1 promotes elesclomol-induced PANoptosis in diffuse large B-cell lymphoma via activating IRF3/IFN-beta signaling.
   Oncogene. 2025 Apr 16. doi: 10.1038/s41388-025-03366.
   

   >> Share

   
   January 2025
2. ABD-ELRAHMAN I, Nassar T, Khairi N, Perlman R, et al
   Correction: Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma.
   Oncogene. 2025 Jan 29. doi: 10.1038/s41388-025-03282.
   

   >> Share

   
   November 2024
3. BORDONE R, Ivy DM, D'Amico R, Barba M, et al
   MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation.
   Oncogene. 2024;43:3349-3365.
   

   >> Share

   
   September 2023
4. MOLINA E, Garcia-Gutierrez L, Junco V, Perez-Olivares M, et al
   MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.
   Oncogene. 2023 Sep 29. doi: 10.1038/s41388-023-02846.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share